S&P 500   4,009.56 (+0.96%)
DOW   32,588.39 (+0.60%)
QQQ   311.00 (+1.26%)
AAPL   159.80 (+1.36%)
MSFT   279.18 (+1.44%)
META   203.43 (+1.37%)
GOOGL   101.42 (+0.39%)
AMZN   99.61 (+2.44%)
TSLA   191.38 (+1.16%)
NVDA   268.44 (+1.64%)
NIO   9.60 (+4.35%)
BABA   100.25 (+1.88%)
AMD   95.78 (+1.29%)
T   18.92 (+1.07%)
F   11.92 (+2.76%)
MU   62.86 (+6.04%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   95.86 (+1.10%)
AMC   4.90 (-4.85%)
PFE   40.17 (+0.45%)
PYPL   73.67 (+1.33%)
NFLX   328.43 (+1.52%)
S&P 500   4,009.56 (+0.96%)
DOW   32,588.39 (+0.60%)
QQQ   311.00 (+1.26%)
AAPL   159.80 (+1.36%)
MSFT   279.18 (+1.44%)
META   203.43 (+1.37%)
GOOGL   101.42 (+0.39%)
AMZN   99.61 (+2.44%)
TSLA   191.38 (+1.16%)
NVDA   268.44 (+1.64%)
NIO   9.60 (+4.35%)
BABA   100.25 (+1.88%)
AMD   95.78 (+1.29%)
T   18.92 (+1.07%)
F   11.92 (+2.76%)
MU   62.86 (+6.04%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   95.86 (+1.10%)
AMC   4.90 (-4.85%)
PFE   40.17 (+0.45%)
PYPL   73.67 (+1.33%)
NFLX   328.43 (+1.52%)
S&P 500   4,009.56 (+0.96%)
DOW   32,588.39 (+0.60%)
QQQ   311.00 (+1.26%)
AAPL   159.80 (+1.36%)
MSFT   279.18 (+1.44%)
META   203.43 (+1.37%)
GOOGL   101.42 (+0.39%)
AMZN   99.61 (+2.44%)
TSLA   191.38 (+1.16%)
NVDA   268.44 (+1.64%)
NIO   9.60 (+4.35%)
BABA   100.25 (+1.88%)
AMD   95.78 (+1.29%)
T   18.92 (+1.07%)
F   11.92 (+2.76%)
MU   62.86 (+6.04%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   95.86 (+1.10%)
AMC   4.90 (-4.85%)
PFE   40.17 (+0.45%)
PYPL   73.67 (+1.33%)
NFLX   328.43 (+1.52%)
S&P 500   4,009.56 (+0.96%)
DOW   32,588.39 (+0.60%)
QQQ   311.00 (+1.26%)
AAPL   159.80 (+1.36%)
MSFT   279.18 (+1.44%)
META   203.43 (+1.37%)
GOOGL   101.42 (+0.39%)
AMZN   99.61 (+2.44%)
TSLA   191.38 (+1.16%)
NVDA   268.44 (+1.64%)
NIO   9.60 (+4.35%)
BABA   100.25 (+1.88%)
AMD   95.78 (+1.29%)
T   18.92 (+1.07%)
F   11.92 (+2.76%)
MU   62.86 (+6.04%)
CGC   1.83 (+1.10%)
GE   94.15 (+1.08%)
DIS   95.86 (+1.10%)
AMC   4.90 (-4.85%)
PFE   40.17 (+0.45%)
PYPL   73.67 (+1.33%)
NFLX   328.43 (+1.52%)
NASDAQ:NBIX

Neurocrine Biosciences - NBIX Institutional Ownership

$96.75
+0.34 (+0.35%)
(As of 03/29/2023 11:26 AM ET)
Add
Compare
Today's Range
$95.90
▼
$97.26
50-Day Range
$94.11
▼
$111.36
52-Week Range
$75.25
▼
$129.29
Volume
81,491 shs
Average Volume
818,892 shs
Market Capitalization
$9.35 billion
P/E Ratio
63.24
Dividend Yield
N/A
Price Target
$125.65

Institutional Ownership Changes (13F Filings) for Neurocrine Biosciences (NASDAQ:NBIX)

Current
Institutional Ownership
Percentage
92.58%
Number of
Institutional Buyers
(last 12 months)
324
Total
Institutional Inflows
(last 12 months)
$1.51 B
Number of
Institutional Sellers
(last 12 months)
233
Total
Institutional Outflows
(last 12 months)
$3.97 B
Skip Chart & View Institutional Buying and Selling Data

NBIX Institutional Buying and Selling by Quarter

Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Neurocrine Biosciences Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/27/2023Neo Ivy Capital Management2,682$0.32M0.2%+1,390.0%0.003%
3/10/2023Victory Capital Management Inc.113,338$13.54M0.0%+15.8%0.117%
2/28/2023Voya Investment Management LLC161,811$19.33M0.0%+29.4%0.168%
2/24/2023Natixis44,649$5.33M0.0%N/A0.046%
2/22/2023Teachers Retirement System of The State of Kentucky42,812$5.11M0.1%+81.5%0.044%
2/21/2023Macquarie Group Ltd.285,314$34.08M0.0%-0.3%0.295%
2/21/2023Wallace Advisory Group LLC1,702$0.20M0.2%N/A0.002%
2/21/2023Northwestern Mutual Investment Management Company LLC8,897$1.06M0.0%-35.6%0.009%
2/17/2023Truist Financial Corp42,338$5.06M0.0%-3.9%0.044%
2/17/2023Coppell Advisory Solutions Corp.423$51K0.0%N/A0.000%
2/17/2023Covenant Partners LLC1,943$0.23M0.1%N/A0.002%
2/17/2023Linden Thomas Advisory Services LLC15,024$1.79M0.5%N/A0.016%
2/16/2023DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main52,147$6.23M0.0%+48.1%0.054%
2/16/2023Axxcess Wealth Management LLC10,664$1.27M0.1%N/A0.011%
2/16/2023American Trust6,530$0.78M0.1%N/A0.007%
2/16/2023Alliancebernstein L.P.166,861$19.93M0.0%+7.5%0.173%
2/16/2023HealthCor Management L.P.20,000$2.39M2.2%-7.9%0.021%
2/16/2023Point72 Middle East FZE4,507$0.54M0.0%N/A0.005%
2/16/2023State of Wyoming1,756$0.21M0.1%+487.3%0.002%
2/15/2023Public Employees Retirement System of Ohio48,584$5.80M0.0%+2.1%0.051%
2/15/2023MetLife Investment Management LLC64,270$7.68M0.1%-1.6%0.067%
2/15/2023State of Tennessee Treasury Department46,279$5.53M0.0%+27.6%0.048%
2/15/2023Apollon Wealth Management LLC1,734$0.21M0.0%N/A0.002%
2/15/2023Utah Retirement Systems16,783$2.01M0.0%-1.2%0.017%
2/15/2023Captrust Financial Advisors2,946$0.35M0.0%+52.7%0.003%
2/15/2023Lazard Asset Management LLC4,235$0.51M0.0%+252.0%0.004%
2/15/20231832 Asset Management L.P.691,400$82.58M0.2%+45.6%0.719%
2/15/2023Bridgefront Capital LLC2,894$0.35M0.2%N/A0.003%
2/15/2023Cerity Partners LLC3,239$0.39M0.0%+19.7%0.003%
2/15/2023Vestcor Inc13,442$1.61M0.1%+91.6%0.014%
2/15/2023State of Wisconsin Investment Board64,195$7.67M0.0%-8.5%0.067%
2/15/2023Schonfeld Strategic Advisors LLC47,600$5.69M0.0%-31.5%0.050%
2/15/2023Squarepoint Ops LLC33,522$4M0.0%-41.9%0.035%
2/15/2023Legal & General Group Plc491,222$58.67M0.0%-1.2%0.511%
2/15/2023Lombard Odier Asset Management Switzerland SA137,450$16.42M1.3%-31.0%0.143%
2/15/2023Mackenzie Financial Corp39,469$4.71M0.0%+11.3%0.041%
2/15/2023Marietta Investment Partners LLC3,580$0.43M0.1%N/A0.004%
2/15/2023Millennium Management LLC840,340$100.37M0.1%+46.6%0.874%
2/15/2023Money Concepts Capital Corp467$56K0.0%N/A0.000%
2/15/2023Man Group plc315,970$37.74M0.1%+199.0%0.329%
2/15/2023Mariner LLC10,597$1.27M0.0%-10.0%0.011%
2/15/2023Nissay Asset Management Corp Japan ADV10,825$1.29M0.0%-2.1%0.011%
2/15/2023Norges Bank935,915$111.79M0.0%N/A0.974%
2/15/2023E Fund Management Co. Ltd.3,606$0.43M0.0%-19.4%0.004%
2/15/2023Eagle Asset Management Inc.278,485$33.44M0.2%N/A0.290%
2/15/2023EAM Global Investors LLC16,774$2M0.5%N/A0.017%
2/15/2023EAM Investors LLC13,187$1.58M0.3%-1.2%0.014%
2/15/2023Echo Street Capital Management LLC2,036$0.24M0.0%N/A0.002%
2/15/2023Fjarde AP Fonden Fourth Swedish National Pension Fund21,800$2.60M0.0%-19.6%0.023%
2/15/2023Fred Alger Management LLC206,697$24.69M0.1%+92,175.4%0.215%
2/15/2023FinTrust Capital Advisors LLC2,500$0.30M0.1%N/A0.003%
2/15/2023Allstate Investment Management Co.4,215$0.50M0.0%N/A0.004%
2/15/2023AQR Capital Management LLC106,535$12.69M0.0%-6.2%0.111%
2/15/2023Armistice Capital LLC900,000$107.50M1.9%-32.0%0.936%
2/15/2023Artia Global Partners LP45,000$5.38M2.0%N/A0.047%
2/15/2023Ascendant Capital Management LLC3,000$0.36M1.1%N/A0.003%
2/15/2023Avidity Partners Management LP1,780,000$212.60M4.6%-4.1%1.852%
2/15/2023Axxcess Wealth Management LLC10,664$1.27M0.1%N/A0.011%
2/15/2023Caisse DE Depot ET Placement DU Quebec44,376$5.30M0.0%+94.0%0.046%
2/15/2023Jefferies Financial Group Inc.22,231$1.73M0.0%N/A0.023%
2/14/2023Meeder Asset Management Inc.1,227$0.15M0.0%-72.3%0.001%
2/14/2023Baader Bank Aktiengesellschaft1,700$0.20M0.0%N/A0.002%
2/14/2023DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main52,147$6.23M0.0%+48.1%0.054%
2/14/2023Price T Rowe Associates Inc. MD1,425,290$170.24M0.0%-2.6%1.483%
2/14/2023Verition Fund Management LLC4,766$0.57M0.0%+67.6%0.005%
2/14/2023Cetera Advisor Networks LLC2,151$0.26M0.0%N/A0.002%
2/14/2023Cetera Investment Advisers1,982$0.24M0.0%N/A0.002%
2/14/2023Amundi923,366$102.02M0.1%+13.0%0.961%
2/14/2023Laurel Wealth Advisors Inc.1,719$0.21M0.0%-10.8%0.002%
2/14/2023Marshall Wace LLP30,446$3.64M0.0%N/A0.032%
2/14/2023Nelson Van Denburg & Campbell Wealth Management Group LLC2,282$0.27M0.0%-41.2%0.002%
2/14/2023Two Sigma Advisers LP722,673$86.32M0.2%+21.5%0.752%
2/14/2023Campbell & CO Investment Adviser LLC4,094$0.49M0.1%-31.5%0.004%
2/14/2023Two Sigma Investments LP571,021$68.20M0.2%+54.8%0.594%
2/14/2023Arrowstreet Capital Limited Partnership64,226$7.67M0.0%-69.0%0.067%
2/14/2023Engineers Gate Manager LP4,097$0.49M0.0%N/A0.004%
2/14/2023Driehaus Capital Management LLC241,258$28.82M0.4%+8.4%0.251%
2/14/2023Qtron Investments LLC4,731$0.57M0.1%+146.9%0.005%
2/14/2023Townsquare Capital LLC23,809$2.84M0.1%-10.1%0.025%
2/13/2023Advisors Asset Management Inc.27,358$3.27M0.1%+26.8%0.028%
2/13/2023First Republic Investment Management Inc.11,069$1.32M0.0%+1.0%0.012%
2/13/2023Charles Schwab Investment Management Inc.566,039$67.61M0.0%+4.6%0.589%
2/13/2023Brown Advisory Inc.1,061,661$126.81M0.2%-1.2%1.104%
2/13/2023Baird Financial Group Inc.17,472$2.09M0.0%N/A0.018%
2/13/2023BOKF NA5,057$0.60M0.0%+5.5%0.005%
2/13/2023CIBC Asset Management Inc3,093$0.37M0.0%-27.3%0.003%
2/13/2023Bessemer Group Inc.342$42K0.0%+755.0%0.000%
2/13/2023Panagora Asset Management Inc.10,969$1.31M0.0%-18.8%0.011%
2/13/2023Natixis23,149$2.76M0.0%N/A0.024%
2/13/2023Seeyond20,524$2.45M0.2%-12.8%0.021%
2/13/2023Shelton Capital Management4,897$0.59M0.1%-2.4%0.005%
2/13/2023Renaissance Technologies LLC1,613,664$192.74M0.3%+11.9%1.679%
2/13/2023Edgestream Partners L.P.18,154$2.17M0.2%+106.6%0.019%
2/13/2023The Manufacturers Life Insurance Company 101,117$12.10M0.0%-1.3%0.105%
2/13/2023Seven Eight Capital LP1,804$0.22M0.1%N/A0.002%
2/13/2023ExodusPoint Capital Management LP73,006$8.72M0.1%+43.2%0.076%
2/13/2023Credit Suisse AG206,916$24.71M0.0%-0.1%0.215%
2/13/2023Martingale Asset Management L P21,723$2.60M0.1%N/A0.023%
2/13/2023Geode Capital Management LLC1,388,695$165.69M0.0%+5.4%1.445%
2/13/2023BI Asset Management Fondsmaeglerselskab A S4,414$0.53M0.0%N/A0.005%
(Data available from 1/1/2016 forward)













NBIX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NBIX shares?

During the previous two years, 517 institutional investors and hedge funds held shares of Neurocrine Biosciences. The most heavily invested institutionals were BlackRock Inc. ($1.28B), Vanguard Group Inc. ($955.99M), Janus Henderson Group PLC ($861.87M), State Street Corp ($400.06M), Bellevue Group AG ($303.25M), JPMorgan Chase & Co. ($259.19M), and Avidity Partners Management LP ($212.60M).Learn more on NBIX's institutional investors.

What percentage of Neurocrine Biosciences stock is owned by institutional investors?

92.58% of Neurocrine Biosciences stock is owned by institutional investors. Learn more on NBIX's institutional investor holdings.

Which institutional investors have been buying Neurocrine Biosciences stock?

Of the 448 institutional investors that purchased Neurocrine Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deerfield Management Company L.P. Series C ($2.01M), PFM Health Sciences LP ($1.12M), Eaton Vance Management ($0.94M), Norges Bank ($0.94M), Los Angeles Capital Management LLC ($0.79M), Polar Capital Holdings Plc ($0.73M), and Principal Financial Group Inc. ($0.72M).

How much institutional buying is happening at Neurocrine Biosciences?

Institutional investors have bought a total of 29,876,368 shares in the last 24 months. This purchase volume represents approximately $2.97B in transactions.

Which Neurocrine Biosciences major shareholders have been selling company stock?

Of the 306 institutional investors that sold Neurocrine Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Allianz Asset Management GmbH ($46.50M), Lazard Asset Management LLC ($25.66M), UBS Asset Management Americas Inc. ($25.45M), Goldman Sachs Group Inc. ($10.24M), State Street Corp ($8.35M), BNP Paribas Arbitrage SA ($6.23M), and Price T Rowe Associates Inc. MD ($4.11M).

How much institutional selling is happening at Neurocrine Biosciences?

Institutional investors have sold a total of 156,032,114 shares in the last 24 months. This volume of shares sold represents approximately $15B in transactions.

This page (NASDAQ:NBIX) was last updated on 3/29/2023 by MarketBeat.com Staff